Data protection Impressum

Financing

Start-ups Aseptuva, Bloom Biorenewables, and Hafnova have been selected for multi-year EU-funded projects, reinforcing Western Switzerland’s importance in health tech, sustainable chemistry and cybersecurity.

Three rising Western Switzerland start-ups join major European innovation programs

3 June 2025

Hedera Dx has secured EUR 15 million to expand hospital-based cancer diagnostics, making precision oncology more accessible to patients worldwide.

Hedera Dx raises EUR 15 million to expand access to precision cancer care

27 May 2025

Geneva-based Syrhatech has raised CHF 4.5 million to expand its R&D and manufacturing of injectable hyaluronic acid-based medical devices to support growing demand in dermatology, orthopedics, and ophthalmology.

Syrhatech raises CHF 4.5 million to innovate in hyaluronic acid medical devices

27 May 2025

Lausanne-based biotech ReproNovo has secured USD 65 million to advance Phase 2 trials for novel therapies in male infertility and women’s reproductive health.

ReproNovo raises USD 65 million to advance trials in reproductive health

21 May 2025

Colb Asset SA, a Geneva-based fintech company specializing in real-world asset tokenization, has secured CHF 6 million in an oversubscribed seed extension round. The funding aims to broaden access to traditionally exclusive investment opportunities through blockchain technology.

Geneva-based Colb raises CHF 6 million to tokenize pre-IPO investments on blockchain

13 May 2025

DemoSquare has successfully raised CHF 1.2 million in pre-seed funding to fuel its expansion into European markets, aiming to enhance its AI-based platform for monitoring political and regulatory activities.

DemoSquare launches EU platform in Brussels to expand AI-based policy monitoring

13 May 2025

The Lausanne Region Trophy at the 23rd Prix Entreprendre Lausanne Région (PERL) ceremony has been awarded to Carewell, a Pully-based start-up optimizing healthcare staffing through a digital platform that merges technological and social innovation.

Carewell wins 2025 PERL Award for innovation in healthcare staffing

12 May 2025

HAYA Therapeutics, a precision medicine company based at Biopôle in Lausanne, has closed a USD 65 million Series A funding round to accelerate the clinical development of its RNA-guided therapies and expand its regulatory genome platform.

HAYA Therapeutics raises USD 65 million to advance RNA-guided therapies for chronic disease

12 May 2025

NovaMea, a cleantech start-up from the EPFL, has raised USD 3.2 million to advance the research and development of its green hydrogen production technology.

NovaMea raises USD 9 million to scale green hydrogen production technologies

6 May 2025

Four innovative Geneva-based start-ups have received funding from the FONGIT Innovation Fund (FIF), highlighting the canton’s continued support for impactful technologies in life sciences and sustainable mobility.

Geneva-based start-ups awarded FIF funding to accelerate innovation in health and mobility

5 May 2025

1 2 3 4 5 … 32